Given PRMT5 is consistently overexpressed in RT tissues and in CLL eventually undergoing RT, we developed the Eμ-PRMT5/TCL1 model to evaluate a role for PRMT5 in CLL progression to RT. This evidence concerns the gene PRMT5 and B-cell chronic lymphocytic leukemia.